1. Signaling Pathways
  2. Anti-infection
  3. Parasite
  4. Plasmodium Isoform
  5. Plasmodium Inhibitor

Plasmodium Inhibitor

Plasmodium Inhibitors (108):

Cat. No. Product Name Effect Purity
  • HY-17589A
    Chloroquine
    Inhibitor 99.98%
    Chloroquine is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis.
  • HY-17589
    Chloroquine phosphate
    Inhibitor 99.96%
    Chloroquine phosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis.
  • HY-N0176
    Dihydroartemisinin
    Inhibitor 99.03%
    Dihydroartemisinin is a potent anti-malaria agent.
  • HY-B1370
    Hydroxychloroquine sulfate
    Inhibitor 99.99%
    Hydroxychloroquine sulfate (HCQ sulfate) is a synthetic antimalarial agent which can also inhibit Toll-like receptor 7/9 (TLR7/9) signaling.
  • HY-W031727
    Hydroxychloroquine
    Inhibitor ≥98.0%
    Hydroxychloroquine is a synthetic antimalarial agent which can also inhibit Toll-like receptor 7/9 (TLR7/9) signaling.
  • HY-106866
    Bulaquine
    Inhibitor
    Bulaquine (CDRI 80/53) is a potent antimalarial agent which is an analogue of Primaquine (HY-12651A).
  • HY-148429
    Antimalarial agent 17
    Inhibitor
    Antimalarial agent 17 is an antimalarial agent, also acts as a herbicide.
  • HY-117025
    Manzamine A
    Inhibitor
    Manzamine A, an orally active beta-carboline alkaloid, inhibits specifically GSK-3β and CDK-5 with IC50s of 10.2 μM and 1.5 μM, respectively.
  • HY-B0094
    Artemisinin
    Inhibitor 99.03%
    Artemisinin (Qinghaosu), a sesquiterpene lactone, is an anti-malarial drug isolated from the aerial parts of Artemisia annua L.
  • HY-13832
    Atovaquone
    Inhibitor 99.73%
    Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite’s mitochondrial cytochrome bc1 complex.
  • HY-N0674
    Dehydrocorydaline
    Inhibitor 99.77%
    Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP.
  • HY-17437A
    Mefloquine hydrochloride
    Inhibitor 99.98%
    Mefloquine hydrochloride (Mefloquin hydrochloride), a quinoline antimalarial agent, is an anti-SARS-CoV-2 entry inhibitor.
  • HY-13557
    Ascomycin
    Inhibitor 99.62%
    Ascomycin (Immunomycin; FR-900520; FK520) is an ethyl analog of Tacrolimus (FK506) with strong immunosuppressant properties.
  • HY-103353
    SID 26681509
    Inhibitor 98.26%
    SID 26681509 is a potent, reversible, competitive, and selective inhibitor of human cathepsin L with an IC50 of 56 nM.
  • HY-B0803
    Lumefantrine
    Inhibitor 98.41%
    Lumefantrine is an antimalarial drug, used in combination with Artemether.
  • HY-N0498
    Nitidine chloride
    Inhibitor 99.61%
    Nitidine chloride, a potential anti-malarial lead compound derived from Zanthoxylum nitidum (Roxb) DC, exerts potent anticancer activity through diverse pathways, including inducing apoptosis, inhibiting STAT3 signaling cascade, DNA topoisomerase 1 and 2A, ERK and c-Src/FAK associated signaling pathway.
  • HY-N0281
    Daphnetin
    Inhibitor 99.86%
    Daphnetin (7,8-dihydroxycoumarin), one coumarin derivative can be found in plants of the Genus Daphne, is a potent, oral active protein kinase inhibitor, with IC50s of 7.67 μM, 9.33 μM and 25.01 μM for EGFR, PKA and PKC in vitro, respectively.
  • HY-14932
    Pafuramidine
    Inhibitor 99.21%
    Pafuramidine (DB289) is an orally active prodrug of Furamidine (HY-110137A).
  • HY-N0674A
    Dehydrocorydaline chloride
    Inhibitor 99.72%
    Dehydrocorydaline chloride (13-Methylpalmatine chloride) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP.
  • HY-B1302
    Quinidine hydrochloride monohydrate
    Inhibitor 99.61%
    Quinidine hydrochloride monohydrate is an anti-arrythmic agent which is also a potent blocker of K+ channel with an IC50 of 19.9 μM.